Thromboembolic risk in prostate cancer patients treated with PARP inhibitors: A systematic review and meta-analysis
Background Poly (ADP-ribose) polymerase inhibitors (PARPi) have been associated with
thrombotic events, although the association with thrombosis risk in different cancers remains …
thrombotic events, although the association with thrombosis risk in different cancers remains …
Thromboembolic Risk in Prostate Cancer Patients Treated with PARP Inhibitors: A Systematic Review and Meta-analysis.
SC Yazgan, E Akkus, E Yekeduz… - Critical Reviews in …, 2024 - europepmc.org
Background Poly (ADP-ribose) polymerase inhibitors (PARPi) have been associated with
thrombotic events, although the association with thrombosis risk in different cancers remains …
thrombotic events, although the association with thrombosis risk in different cancers remains …
Thromboembolic risk in prostate cancer patients treated with PARP inhibitors: A systematic review and meta-analysis
SC Yazgan, E Akkus, E Yekeduz, Y Urun - Critical Reviews in Oncology …, 2024 - Elsevier
Background Poly (ADP-ribose) polymerase inhibitors (PARPi) have been associated with
thrombotic events, although the association with thrombosis risk in different cancers remains …
thrombotic events, although the association with thrombosis risk in different cancers remains …
Thromboembolic risk in prostate cancer patients treated with PARP inhibitors: A systematic review and meta-analysis
S YAZGAN, E AKKUŞ, E Yekeduz… - Critical Reviews in …, 2024 - avesis.ankara.edu.tr
Background: Poly (ADP-ribose) polymerase inhibitors (PARPi) have been associated with
thrombotic events, although the association with thrombosis risk in different cancers remains …
thrombotic events, although the association with thrombosis risk in different cancers remains …
Thromboembolic Risk in Prostate Cancer Patients Treated with PARP Inhibitors: A Systematic Review and Meta-analysis
SC Yazgan, E Akkus, E Yekeduz… - Critical reviews in … - pubmed.ncbi.nlm.nih.gov
Background Poly (ADP-ribose) polymerase inhibitors (PARPi) have been associated with
thrombotic events, although the association with thrombosis risk in different cancers remains …
thrombotic events, although the association with thrombosis risk in different cancers remains …